Insight Molecular Diagnostics Inc (IMDX)

07:30 AM

Insight Molecular Diagnostics names Steven Tahmooressi as VP, marketing - Medical Buyer

07:30 AM

Oct 13, 2025

Insight Molecular Diagnostics appoints Steven Tahmooressi as VP of Marketing - Investing.com Nigeria

Oct 13, 2025

Oct 13, 2025

Imdx welcomes new VP Marketing to prepare for commercial transplant assay launch - MarketScreener

Oct 13, 2025

Oct 13, 2025

iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch - GlobeNewswire

Oct 13, 2025

Oct 13, 2025

GraftAssureDx kit launching 2026: iMDx hires Steven Tahmooressi as VP Marketing to lead global rollout - Stock Titan

Oct 13, 2025

Oct 13, 2025

What earnings margins imply for Insight Molecular Diagnostics Inc. (7OC0) stockQuarterly Trade Review & Long-Term Growth Portfolio Plans - newser.com

Oct 13, 2025

Oct 10, 2025

Is Insight Molecular Diagnostics Inc. (7OC0) stock included in top ETFsJuly 2025 Patterns & Community Consensus Trade Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Is Insight Molecular Diagnostics Inc. (7OC0) stock dividend growth reliable - newser.com

Oct 09, 2025

Oct 09, 2025

Will Insight Molecular Diagnostics Inc. (7OC0) stock attract long term capital inflowsQuarterly Profit Report & Accurate Technical Buy Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

Bullish Insight Molecular Diagnostics Insiders Rewarded As Their Investment Rises To US$4.85m - simplywall.st

Oct 08, 2025

Oct 08, 2025

Insight Molecular Diagnostics Inc.'s (NASDAQ:IMDX) large hedge funds owners must be happy as stock continues to impress, up 12% over the past week - Yahoo Finance

Oct 08, 2025

Oct 07, 2025

iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset’ with Novel Therapy and GraftAssure Monitoring - Sahm

Oct 07, 2025

Oct 06, 2025

Insight Molecular Diagnostics stock rises after transplant study publication - Investing.com

Oct 06, 2025

Oct 06, 2025

Insight Molecular Says GraftAssure Assay Helped Avoid Overtreatment in Kidney Transplant Patient - MarketScreener

Oct 06, 2025

Oct 06, 2025

IMDX's GraftAssure Assay Shows Promise in Kidney Transplant Moni - GuruFocus

Oct 06, 2025

Oct 06, 2025

GraftAssure test helps monitor kidney transplant patient during cancer therapy By Investing.com - Investing.com Nigeria

Oct 06, 2025

Oct 06, 2025

Imdx reports kidney transplant patient achieved 'immune reset' with novel therapy and GraftAssure monitoring - MarketScreener

Oct 06, 2025

Oct 05, 2025

Molecular Diagnostics Market Analysis: Trends, Opportunities, and Forecast - newstrail.com

Oct 05, 2025

Oct 02, 2025

Why Insight Molecular Diagnostics Inc. (7OC0) stock benefits from AI revolutionJuly 2025 Price Swings & Community Trade Idea Sharing Platform - newser.com

Oct 02, 2025

Oct 02, 2025

Insight Molecular Diagnostics Extends Executive Employment Agreement - TipRanks

Oct 02, 2025

Oct 02, 2025

Insight Molecular Diagnostics grants stock options to executives and amends employment agreement - Investing.com

Oct 02, 2025

Sep 30, 2025

What analysts say about Insight Molecular Diagnostics Inc 7OC0 stockContrarian Investment Ideas & Stay Invested. Stay Smart. - earlytimes.in

Sep 30, 2025

Sep 27, 2025

Lake Street Maintains Insight Molecular Diagnostics(IMDX.US) With Buy Rating, Maintains Target Price $8 - 富途牛牛

Sep 27, 2025

Sep 26, 2025

Autoimmune Disease Diagnostics Market Size Report, 2034 - Global Market Insights Inc.

Sep 26, 2025

Sep 26, 2025

Why Insight Molecular Diagnostics Inc. (7OC0) stock fits value portfoliosQuarterly Market Review & Smart Allocation Stock Tips - newser.com

Sep 26, 2025

Sep 26, 2025

Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) - The Globe and Mail

Sep 26, 2025

Sep 25, 2025

Molecular Diagnostics in Pharmacogenomics Market to Reach USD - openPR.com

Sep 25, 2025

Sep 24, 2025

HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer? - TradingView

Sep 24, 2025

Sep 24, 2025

Insight Molecular Diagnostics (IMDX) Highlights GraftAssur at In - GuruFocus

Sep 24, 2025

Sep 24, 2025

Analysts’ Top Healthcare Picks: CareDx (CDNA), Semler Scientific (SMLR) - The Globe and Mail

Sep 24, 2025

Sep 24, 2025

Insight Molecular Diagnostics to Showcase Leadership in - GlobeNewswire

Sep 24, 2025

Sep 24, 2025

Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando - MarketScreener

Sep 24, 2025

Sep 19, 2025

Insight Molecular Diagnostics Approves Executive Salary Increases - TipRanks

Sep 19, 2025

Sep 16, 2025

Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East - Quantisnow

Sep 16, 2025

Sep 15, 2025

North America In Vitro Diagnostics (IVD) Market Insights and Future Outlook - openPR.com

Sep 15, 2025

Sep 13, 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Sep 13, 2025

Sep 09, 2025

Lake Street Remains a Buy on Insight Molecular Diagnostics (IMDX) - The Globe and Mail

Sep 09, 2025

Sep 08, 2025

iMDx launches 5,000-patient registry to study transplant rejection test - Investing.com

Sep 08, 2025

Sep 08, 2025

iMDx launches 5,000-patient registry to study transplant rejection test By Investing.com - Investing.com Nigeria

Sep 08, 2025

Sep 08, 2025

Insight Molecular Diagnostics (IMDX) Launches New Patient Regist - GuruFocus

Sep 08, 2025

Sep 08, 2025

IMDX Advances GraftAssureDx Clinical Trial for Transplant Rejection Test - GuruFocus

Sep 08, 2025

Sep 08, 2025

Insight Molecular Diagnostics Inc. Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants - MarketScreener

Sep 08, 2025